Recombinant monoclonal antibody to MUC1. Gatipotuzumab is a human monoclonal antibody that can be potentially used in the treatment of Solid tumors.
Figure 1 Impact of Gatipotuzumab and 4-Hydroxy-Tamoxifen (4-OHT) on OC viability.
Stimulation with Gatipotuzumab, 4-OHT and the combination of the two was performed in COV318, OV-90, SKOV-3, and OVCAR-3 cell lines over a 48-h and 72-h period. In general, Gatipotuzumab (Gati) alone only moderately reduced cell viability, while 4-OHT treatment appeared to be efficient in all the four cell lines tested (A-D). When viability of cells that had undergone co-stimulation was compared to that of those that had been treated with a single substance only, the overall net effect of co-stimulation was numerically slightly higher than the sum of individual effects of any of the two substances alone OVCAR-3 (C) and SKOV-3 (D). However, this was not statistically significant.
Heublein, S., Page, S., Mayr, D., Schmoeckel, E., Trillsch, F., Marmé, F.,... & Vattai, A. (2019). Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer. International journal of molecular sciences, 20(2), 295.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-MUC1 ADCC Recombinant Antibody (Gatipotuzumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to MUC1. Gatipotuzumab is a human monoclonal antibody that can be potentially used in the treatment of Solid tumors.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-2049-VHH | Recombinant Anti-human MUC1 VHH Single Domain Antibody | WB, IP, ChiP, Neut, ELISA | Llama VHH |
HPAB-AP504-YC | Recombinant Camel Anti-MUC1 Single Domain Antibody (HPAB-AP504-YC) | FC | Camel VHH |
HPAB-AP505-YC | Recombinant Camel Anti-MUC1 Single Domain Antibody (HPAB-AP505-YC) | ELISA | Camel VHH |
HPAB-0736-YJ-VHH | Camelid Anti-MUC1 Recombinant Single Domain Antibody (HPAB-0736-YJ-VHH) | ELISA | Camelid VHH |
HPAB-0737-YJ-VHH | Camelid Anti-MUC1 Recombinant Single Domain Antibody (HPAB-0737-YJ-VHH) | ELISA | Camelid VHH |
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-026ML, RRID: AB_3111759)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.